D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 290, Issue 1, 2006, Pages

  Yang, Zhiwei ^a,b   Asico, Laureano D ^b   Yu, Peiying ^b   Wang, Zheng ^b   Jones, John E ^b   Escano, Crisanto S ^b   Wang, Xiaoyan ^b   Quinn, Mark T ^c   Sibley, David R ^d   Romero, Guillermo G ^e   Felder, Robin A ^f   Jose, Pedro A ^b  

^a INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; APOCYNIN; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR D5; FENOLDOPAM; GLYCOPROTEIN GP 91; OXYTOCIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; VASOPRESSIN V1 RECEPTOR; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; KIDNEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BLOOD PRESSURE; CELL LINE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BLOOD PRESSURE; CELL LINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FENOLDOPAM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; MICE, KNOCKOUT; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; RECEPTORS, DOPAMINE D5; SODIUM CHLORIDE;

EID: 33644833318     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00434.2005     Document Type: Article

References (61)

1. Allayee H, de Bruin TW, Dominguez KM, Cheng LS, Ipp E, Cantor RM, Krass KL, Keulen ET, Aouizerat BE, Lusis AJ, and Rotter JI. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 38: 773-778, 2001.
2. Bianchi P, Seguelas MH, Parini A, and Cambon C. Activation of pro-apoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases. J Am Soc Nephrol 14: 855-862, 2003.
3. Burgess LH, Monsma FJ Jr, Shen Y, Jose PA, and Sibley DR. Further characterization of D1A and D1B dopamine receptors in rat kidney (Abstract). Soc Neurosci Abstr 19: 75, 1993.
4. Burritt JB, Quinn MT, Jutila MA, Bond CW, and Jesaitis AJ. Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries. J Biol Chem 270: 16974-16980, 1995.
5. Butz GM and Davisson RL. Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics 5: 89-97, 2001.
6. Cai H, Griendling KK, and Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24: 471-478, 2003.
7. Carey RM. Theodore Cooper Lecture: Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 38: 297-302, 2001.
8. Carvey PM, McGuire SO, and Ling ZD. Neuroprotective effects of D3 dopamine receptor agonists. Parkinsonism Relat Disord 7: 213-223, 2001.
9. Casari G, Barlassina C, Cusi D, Zagato L, Muirhead R, Righetti M, Nembri P, Amar K, Gatti M, Macciardi F, Binelli, G, and Bianchi G. Association of the alpha-adducin locus with essential hypertension. Hypertension 25: 320-326, 1995.
10. Chen CJ and Lokhandwala MF. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens 14: 615-628, 1992.
11. Chen J, Wersinger C, and Sidhu A. Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity. J Biol Chem 278: 28089-28100, 2003.
12. Chini CC, Grande JP, Chini EN, and Dousa TP. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis. J Biol Chem 272: 9854-9859, 1997.
13. Cohn DH, Shohat T, Yahav M, Ilan T, Rechavi G, King L, and Shohat M. A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21. Am J Hum Genet 67: 647-651, 2000.
14. Cooper RS, Luke A, Zhu X, Kan D, Adeyemo A, Rotimi C, Bouzekri N, Ward R, and Rorimi C. Genome scan among Nigerians linking blood pressure to chromosomes 2, 3, and 19. Hypertension 40: 629-633, 2002.
15. Cravchik A and Gejman PV. Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics 9: 199-206, 1999.
16. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, and Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 99: 3872-3877, 2002.
17. Felder RA, Seikaly MG, Cody P, Eisner GM, and Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 15: 560-569, 1990.
18. Fontayne A, Dang PM, Gougerot-Pocidalo MA, and El-Benna J. Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 41: 7743-7750, 2002.
19. Fujii M, Hara H, Meng W, Vonsattel JP, Huang Z, and Moskowitz MA. Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke 28: 1805-1810, 1997.
20. Garvin JL and Ortiz PA. The role of reactive oxygen species in the regulation of tubular function. Acta Physiol Scand 179: 225-232, 2003.
21. Geiszt M, Kopp JB, Varnai P, and Leto TL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97: 8010-8014, 2000.
22. Ginn DI, Baptista CA, Alam KY, Deng AY, Dene H, Le H, Kurtz TW, and Rapp JP. Genetic analysis of alpha 2-adrenergic receptors and blood pressure using Dahl salt-sensitive rats. J Hypertens 12: 357-365, 1994.
23. Grandy DK, Allen LJ, Zhang Y, Magenis RE, and Civelli O. Chromosomal localization of three human D5 dopamine receptor genes. Genomics 13: 968-973, 1992.
24. Gromada J, Rorsman P, Dissing S, and Wulff BS. Stimulation of cloned human glucagon-like peptide 1 receptor expressed in HEK 293 cells induces cAMP-dependent activation of calcium-induced calcium release. FEBS Lett 373: 182-186, 1995.
25. Guyton AC, Hall JE, Coleman TG, Manning RD Jr, and Norman RA Jr. The dominant role of the kidneys in long term arterial pressure regulation in normal and hypertensive states. In: Hypertension: Pathophysiology, Diagnosis, and Management (2nd ed.), edited by Laragh JH and Brenner BM, New York: Raven, 1995, p. 1311-1313.
26. Hartner A, Cordasic N, Klanke B, Veelken R, and Hilgers KF. Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice. Nephrol Dial Transplant 18: 1999-2004, 2003.
27. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, Drago J, Young WS III, Westphal H, Jose PA, and Sibley DR. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 22: 10801-10810, 2002.
28. Hussain T, and Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 228: 134-142, 2003.
29. Immenschuh S, Kietzmann T, Hinke V, Wiederhold M, Katz N, and Muller-Eberhard U. The rat heme oxygenase-1 gene is transcriptionally induced via the protein kinase A signaling pathway in rat hepatocyte cultures. Mol Pharmacol 53: 483-491, 1998.
30. Ishige K, Chen Q, Sagara Y, and Schubert D. The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death. J Neurosci 21: 6069-6076, 2001.
31. Jones D, Morgan C, and Cockcroft S. Phospholipase D and membrane traffic. Potential roles in regulated exocytosis, membrane delivery and vesicle budding. Biochim Biophys Acta 1439: 229-244, 1999.
32. Jose PA, Eisner GM, and Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 11: 87-92, 2002.
33. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, and Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 33: 1353-1358, 1999.
34. 1-like receptor inhibits reactive oxygen species production by interfering with the distribution and assembly of NAD(P)H oxidase components. Council for High Blood Pressure Research, 2005, p. 151.
35. phox in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-α. Circ Res 90: 143-150, 2002.
36. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37:517-554, 1997.
37. Noh JS and Gwag BJ. Attenuation of oxidative neuronal necrosis by a dopamine D1 agonist in mouse cortical cell cultures. Exp Neurol 146: 604-608, 1997.
38. Papadopoulou N, Chen J, Randeva HS, Levine MA, Hillhouse EW, and Grammatopoulos DK. Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity. Mol Endocrinol 18: 624-639, 2004.
39. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, Fisherman J, Orkin SH, Doerschuk CM, and Dinauer MC. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9: 202-209, 1995.
40. Pu Q, Neves MF, Virdis A, Touyz RM, and Schiffrin EL. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension 42: 49-55, 2003.
41. Quinn MT and Gauss KA. Stucture and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidase. J Leukoc Biol 76: 760-781, 2004.
42. Sedlak TW and Snyder SH. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113: 1776-1782, 2004.
43. Shi WX and Bunney BS. Roles of intracellular cAMP and protein kinase A in the actions of dopamine and neurotensin on midbrain dopamine neurons. J Neurosci 12: 2433-2438, 1992.
44. Shome K, Rizzo MA, Vasudevan C, Andresen B, and Romero G. The activation of phospholipase D by endothelin-1, angiotensin II, and platelet-derived growth factor in vascular smooth muscle A10 cells is mediated by small G proteins of the ADP-ribosylation factor family. Endocrinology 141: 2200-2208, 2000.
45. Sibley DR and Monsma FJ Jr. Molecular biology of dopamine receptors. Trends Pharmacol Sci 13: 61-69, 1992.
46. Sprouse J, Reynolds L, Li X, Braselton J, and Schmidt A. 8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production. Neuropharmacology 46: 52-62, 2004.
47. Swain SD, Rohn TT, and Quinn MT. Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid Redox Signal 4: 69-83, 2002.
48. Tiberi M and Caron MG. High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem 269: 27925-27931, 1994.
49. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, and Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90: 1205-1213, 2002.
50. Vecchione C and Brandes RP. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circ Res 91: 173-179, 2002.
51. Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59: 1428-1459, 2002.
52. Virdis A, Neves MF, Amiri F, Touyz RM, and Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 22: 535-542, 2004.
53. Waite KA, Wallin R, Qualliotine-Mann D, and McPhail LC. Phosphatidic acid-mediated phosphorylation of the NADPH oxidase component p47-phox. Evidence that phosphatidic acid may activate a novel protein kinase. J Biol Chem 272: 15569-15578, 1997.
54. 2 production [Online]. Sci. STKE. 2003, PL3.
55. White BH and Sidhu A. Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: a mechanism for defective dopamine D1A receptor/G-protein coupling. J Hypertens 16: 1659-1665, 1998.
56. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand 179: 217-223, 2003.
57. Wingler K, Wunsch S, Kreutz R, Rothermund L, Paul M, and Schmidt HH. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med 31: 1456-1464, 2001.
58. Xia XG, Schmidt N, Teismann P, Ferger B, and Schulz JB. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation. J Neurochem 79: 63-70, 2001.
59. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Bai R, Sibley DR, Felder RA, and Jose PA. D5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 288: H55-H61, 2005.
60. 1-like receptors. Circulation 101: 2302-2308, 2000.
61. Zhang J, Hellwig P, Osborne JP, and Gennis RB. Arginine 391 in subunit I of the cytochrome bd quinol oxidase from Escherichia coli stabilizes the reduced form of the hemes and is essential for quinol oxidase activity. J Biol Chem 279:53980 -53987, 2004.